Drug Shortage Report for PULMICORT TURBUHALER
| Report ID | 153950 |
| Drug Identification Number | 00851752 |
| Brand name | PULMICORT TURBUHALER |
| Common or Proper name | budesonide |
| Company Name | ASTRAZENECA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BUDESONIDE |
| Strength(s) | 200MCG |
| Dosage form(s) | POWDER (METERED DOSE) |
| Route of administration | INHALATION INHALATION |
| Packaging size | 200 inhalations |
| ATC code | R03BA |
| ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2022-02-04 |
| Actual start date | 2022-02-04 |
| Estimated end date | 2022-02-16 |
| Actual end date | 2022-02-14 |
| Shortage status | Resolved |
| Updated date | 2022-02-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2022-02-15 | English | Compare |
| v7 | 2022-02-14 | French | Compare |
| v6 | 2022-02-14 | English | Compare |
| v5 | 2022-02-05 | English | Compare |
| v4 | 2022-02-04 | French | Compare |
| v3 | 2022-02-04 | English | Compare |
| v2 | 2022-01-31 | French | Compare |
| v1 | 2022-01-31 | English | Compare |
Showing 1 to 8 of 8